MedPath

A Comparison of the Outcomes of Distal Fingertip Amputations Treated With Either Artificial (Xeroform) or Biological Dressings

Withdrawn
Conditions
Finger Injuries
Amputation, Traumatic
Interventions
Other: Skin Graft
Other: Bacitracin
Registration Number
NCT03968835
Lead Sponsor
NYU Langone Health
Brief Summary

This is a prospective study looking to evaluate whether the treatment outcomes for patients who sustain a distal fingertip amputation are improved or no different when using biological dressings versus artificial dressings.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • All individuals presenting at Bellevue Hospital for evaluation and treatment of a finger amputation distal to the germinal matrix that present along with the amputated distal fingertip unit.
Read More
Exclusion Criteria
  • replantation candidate, incomplete distal finger-tip amputation
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Artificial DressingsSkin Graftthe amputated composite skin and soft tissue unit will be thinned out to become a full thickness skin graft
Biological DressingsBacitracinBacitracin will be applied and covered with xeroform and gauze
Primary Outcome Measures
NameTimeMethod
Time to complete healing up to 3 Months3 months
Percentage of graft viability (for biological dressing only)3 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

New York University School of Medicine

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath